Correlation of IL-1, IL-6, IL-10 Concentrations to Ovarian Hyperstimulation Syndrome and Effect of Intravenous Immunoglobulin on Ovarian Hyperstimulated Rats

Journal of Reproduction and Contraception

Volumn 19, Issue 3, 2008, Pages 153-159

  ZHANG, Lei ^a   ZHOU, Jing yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

interleukin; intravenous immunoglobulin (IVIG); ovarian hyperstimulation syndrome (OHSS); rat

Indexed keywords

CHORIONIC GONADOTROPIN; EVANS BLUE; GONADOTROPIN; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; NONHUMAN; ORGAN WEIGHT; OVARY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME;

EID: 72149116912     PISSN: 10017844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-7844(08)60018-8     Document Type: Article

References (20)

1. Avecillas J.F., Falcone T., and Arroliga A.C. Ovarian hyperstimulation syndrome. Crit Care Clin 20 4 (2004) 679-695
2. Cannon J.G., and Dinarello C.A. Increased plasma interleukin-l activity in women after ovulation. Science 227 4691 (1985) 1247-1249
3. Karagouni E.E., Chryssikopoulos A., Mantzavinos T., et al. Interleukin-1 beta and interleukinlalpha may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 70 3 (1998) 553-559
4. Artini P.G., Monti M., Fasciani A., et al. Vascular endothehal growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 101 2 (2002) 169-174
5. Abe Y., Horiuchi A., Miyake M., et al. Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev 139 1 (1994) 5-19
6. Polishuk W.Z., and Schenker J.G. Ovarian overstimulation syndrome. Fertil Steril 20 3 (1969) 443-450
7. Ujioka T., Matsuara K., Kawanno T., et al. Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod 12 8 (1997) 1629-1634
8. Fu Y.L., Lin Q.D., and Zhong H.W. Establishment of rat model of the ovarian hyperstimulation syndrome. Shanghai Laboratory Animal Science(in Chinese) 22 1 (2002) 16-19
9. Orvieto R., Voliovitch I., Fishman P., et al. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum Reprod 10 1 (1995) 24-27
10. Friedlander M.A., Loret de Mola J.R., and Goldfarb J.M. Elevated levels of Interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril 60 5 (1993) 826-833
11. Abramov Y., Schenker J.G., Lewin A., et al. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 11 7 (1996) 1381-1386
12. Enskog A., Nilsson L., and Brannstrom M. Low peripheral blood levels of the immunosuppressive cytokine interleukin 10 (IL-10) at the start of gonadotrophin stimulation indicates increased risk for development of ovarian hyperstimulation syndrome (OHSS). J Reprod Immunol 49 1 (2003) 71-85
13. Aboulghar M.A., Mansour R.T., Serour G.I., et al. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 87 1 (1999) 81-85
14. Manolopoulos K., Lang U., Gips H., et al. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 99 2 (2001) 226-231
15. Sapir T., Carp H., and Shoenfeld Y. Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL). Harefuah 144 6 (2005) 415-420 453-4.
16. + cells. Early Pregnancy 4 2 (2000) 90-98
17. Le Pottier L., Sapir T., Bendaoud B., et al. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann N Y Acad Sci 1110 (2007) 426-432
18. Wittstock M., Benecke R., and Zettl U.K. Therapy with intravenous immunoglobulins:complications and sideeffects. Eur Neurol 50 3 (2003) 172-175
19. Orvieto R., and Ben-Rafael Z. The role of the immune system in severe ovarian hyperstimulation syndrome. Med Hypotheses 45 3 (1995) 231-234
20. Orvieto R., Achiron A., Margalit R., et al. The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 15 1 (1998) 46-49